Expression of Angiopoietin-1, Angiopoietin-2, and the Tie-2 receptor tyrosine kinase during mouse kidney maturation

被引:0
|
作者
Yuan, HT
Suri, C
Yancopoulos, GD
Woolf, AS
机构
[1] UCL, Sch Med, Inst Child Hlth, Nephrourol Unit, London WC1EN 1EH, England
[2] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The Tie-2 receptor tyrosine kinase transduces embryonic endothelial differentiation, with Angiopoietin-1 (Ang-1) acting as a stimulatory ligand and Ang-2 postulated to be a naturally occurring inhibitor. Expression of these genes was sought during mouse kidney maturation from the onset of glomerulogenesis (embryonic day 14 [E14]) to the end of nephron formation (2 wk postnatal [P2]), and during medullary maturation into adulthood (P8). Using Northern and slot blotting of RNA extracted from whole organs, these three genes were expressed throughout the experimental period with peak levels at P2 to P3. By in situ hybridization analysis at E18, P1, and P3, Ang-1 mRNA was found to localize to condensing renal mesenchymal cells, proximal tubules, and glomeruli in addition to maturing tubules of the outer medulla. In contrast, Ang-2 transcripts were more spatially restricted, being detected only in differentiating outer medullary tubules and the vasa recta bundle area. Using in situ hybridization and immunohistochemistry, Tie-2 was detected in capillaries of the nephrogenic cortex, glomerular tufts, cortical interstitium, and medulla including vessels in the vasa recta. Using Western blotting of protein extracted from whole organs, Tie-2 protein was detected between E14 and P8 with tyrosine phosphorylated Tie-2 evident from E18. These data are consistent with the hypothesis that Tie-2 has roles in maturation of both glomeruli and vasa rectae.
引用
收藏
页码:1722 / 1736
页数:15
相关论文
共 50 条
  • [41] Expression of angiopoietin-1 and the receptor Tie-2 mRNA in rat brains following intracerebral hemorrhage
    Zhou, HuaJun
    Tang, Tao
    Guo, Canjie
    Zhang, Hainan
    Zhong, JianHua
    Zheng, Jie
    Luo, JieKun
    Lin, Yuan
    Liu, Wei
    Luo, WenFang
    Yang, QiDong
    ACTA NEUROBIOLOGIAE EXPERIMENTALIS, 2008, 68 (02) : 147 - 154
  • [42] Roles of reactive oxygen species in angiopoietin-1/tie-2 receptor signaling
    Harfouche, R
    Abdel-Malak, NA
    Brandes, RP
    Karsan, A
    Irani, K
    Hussain, SNA
    FASEB JOURNAL, 2005, 19 (09): : 1728 - +
  • [43] Decreased Angiopoietin-1 and Tie-2 expression in colon cancer by oxaliplatin administration
    Hwang, D
    Park, J
    Moon, S
    Kim, I
    DISEASES OF THE COLON & RECTUM, 2004, 47 (04) : 569 - 569
  • [44] The Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization
    Asahara, T
    Chen, DH
    Takahashi, T
    Fujikawa, K
    Kearney, M
    Magner, M
    Yancopoulos, GD
    CIRCULATION, 1998, 98 (17) : 730 - 730
  • [45] Association of serum angiopoietin-1, angiopoietin-2 and angiopoietin-2 to angiopoietin-1 ratio with heart failure in patients with acute myocardial infarction
    Chen, Shaomin
    Guo, Lijun
    Chen, Baoxia
    Sun, Lijie
    Cui, Ming
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 5 (03) : 937 - 941
  • [46] Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization
    Asahara, T
    Chen, DH
    Takahashi, T
    Fujikawa, K
    Kearney, M
    Magner, M
    Yancopoulos, GD
    Isner, JM
    CIRCULATION RESEARCH, 1998, 83 (03) : 233 - 240
  • [47] Immunolocalisation of angiopoietin 1, angiopoietin 2 and their receptor Tie-2 in diabetic retinopathy.
    Boulton, ME
    Smith, G
    Hykin, P
    Cree, I
    Boyd, S
    Ahmed, A
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S408 - S408
  • [48] Expression of angiopoietin-1, angiopoietin-2, and Tie2 genes in normal ovary with corpus luteum and in ovarian cancer
    Hata, K
    Udagawa, J
    Fujiwaki, R
    Nakayama, K
    Otani, H
    Miyazaki, K
    ONCOLOGY, 2002, 62 (04) : 340 - 348
  • [49] Angiopoietin-1 and Angiopoietin-2 Inhibitors: Clinical Development
    Gillen, Jessica
    Richardson, Debra
    Moore, Kathleen
    CURRENT ONCOLOGY REPORTS, 2019, 21 (03)
  • [50] Abnormal expression of Angiopoietin-2 and Tie-2 in human cerebral arteriovenous malformations
    Hashimoto, T
    Emala, CW
    Boudreau, NJ
    Quick, CM
    Young, WL
    ANESTHESIOLOGY, 2000, 93 (3A) : U150 - U150